Literature DB >> 17083555

Intravitreal bevacizumab (Avastin) injection associated with regression of retinal neovascularization caused by sickle cell retinopathy.

Rubens C Siqueira, Rogério A Costa, Ingrid U Scott, Léssia P Cintra, Rodrigo Jorge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17083555     DOI： 10.1111/j.1600-0420.2006.00779.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN： 1395-3907


× No keyword cloud information.
  13 in total

1.  Hemoglobin AC retinopathy managed with vitrectomy and adjunctive bevacizumab.

Authors:  R Pokroy; U R Desai
Journal:  Eye (Lond)       Date:  2011-08-05       Impact factor: 3.775

2.  Morphine promotes neovascularizing retinopathy in sickle transgeneic mice.

Authors:  Kalpna Gupta; Chunsheng Chen; Gerard A Lutty; Robert P Hebbel
Journal:  Blood Adv       Date:  2019-04-09

3.  Intravitreal bevacizumab (Avastin) associated with secondary hyphaema in a case of proliferative sickle cell retinopathy.

Authors:  Olufemi Emmanuel Babalola
Journal:  BMJ Case Rep       Date:  2010-03-30

4.  Antiangiogenic therapy for ischemic retinopathies.

Authors:  Motasem Al-Latayfeh; Paolo S Silva; Jennifer K Sun; Lloyd Paul Aiello
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

5.  Intravitreal bevacizumab: an analysis of the evidence.

Authors:  Derrick P Smit; David Meyer
Journal:  Clin Ophthalmol       Date:  2007-09

6.  Effect of multiple injections of small divided doses vs single injection of intravitreal bevacizumab on retinal neovascular model in rabbits.

Authors:  Saloomeh Saati; Rajat N Agrawal; Stan Louie; Gerald J Chader; Mark S Humayun
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-07-31       Impact factor: 3.117

Review 7.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

8.  Role of intravitreal bevacizumab in the management of Eales' disease.

Authors:  Bhuvan Chanana; Raj Vardhan Azad; Sourabh Patwardhan
Journal:  Int Ophthalmol       Date:  2009-01-23       Impact factor: 2.031

Review 9.  Laser therapy for retinopathy in sickle cell disease.

Authors:  Kay Thi Myint; Soumendra Sahoo; Aung Win Thein; Soe Moe; Han Ni
Journal:  Cochrane Database Syst Rev       Date:  2015-10-09

10.  Intravitreal bevacizumab (Avastin) for the treatment of proliferative sickle retinopathy.

Authors:  Saad Shaikh
Journal:  Indian J Ophthalmol       Date:  2008 May-Jun       Impact factor: 1.848
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.